Ruud A.F. Krom

TL;DR: Data suggest that the MELD score is able to accurately predict 3-month mortality among patients with chronic liver disease on the liver waiting list and can be applied for allocation of donor livers.

TL;DR: A number of guidelines were established for creating an index of disease severity to estimate survival in patients with chronic liver disease and it was determined that such a disease severity index should rely on a few, readily available, objective variables that would be generally applicable to a heterogeneous group of patients with end-stage liver disease.

TL;DR: Cardiopulmonary‐related mortality in OLT patients with portopulmonary hypertension was frequent and associated with significantly increased pre‐OLT MPAP, PVR, and TPG compared with survivors, and a prospective study is needed to define optimal pretransplantation treatments and pulmonary hemodynamic criteria that minimize OLT mortality associated with portoperative hypertension.

TL;DR: It is concluded that cyclosporine therapy for immunosuppression in liver transplantation may cause a syndrome of encephalopathy, seizures, and white-matter changes and that this is most likely to occur in patients with low total serum cholesterol levels after transplantation.

TL;DR: It is demonstrated that the development of biliary strictures is strongly associated with the duration of cold ischemic storage of allografts in both Euro‐Collins solution and University of Wisconsin solution and that the occurrence of nonanastomotic biliaryrictures appears to be the result of the ischemia/reperfusion–induced tissue injuryassociated with the harvest and implantation of allogsrafts.